KMPH
Price:
$5.81
Market Cap:
$395.59M
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia (IH). The company's lead product candidate KP1077 which is under Phase II clinical trial for the tre...[Read more]
Industry
Biotechnology
IPO Date
2015-04-16
Stock Exchange
NASDAQ
Ticker
KMPH
According to KemPharm, Inc.’s latest financial reports and current stock price. The company's current ROE is -221.28%. This represents a change of 279.68% compared to the average of -58.28% of the last 4 quarters.
The mean historical ROE of KemPharm, Inc. over the last ten years is 44.53%. The current -221.28% ROE has changed -596.94% with respect to the historical average. Over the past ten years (40 quarters), KMPH's ROE was at its highest in in the June 2016 quarter at 2.59%. The ROE was at its lowest in in the June 2015 quarter at -861.10%.
Average
44.53%
Median
26.07%
Minimum
-266.00%
Maximum
540.10%
Discovering the peaks and valleys of KemPharm, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 619.39%
Maximum Annual ROE = 540.10%
Minimum Annual Increase = -135.03%
Minimum Annual ROE = -266.00%
Year | ROE | Change |
---|---|---|
2024 | -266.00% | 257.35% |
2023 | -74.44% | 53.75% |
2022 | -48.41% | 619.39% |
2021 | -6.73% | -135.03% |
2020 | 19.21% | -41.66% |
2019 | 32.93% | -61.17% |
2018 | 84.83% | 12.45% |
2017 | 75.43% | -14.61% |
2016 | 88.34% | -83.64% |
2015 | 540.10% | 436.72% |
The current ROE of KemPharm, Inc. (KMPH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-129.62%
5-year avg
-75.27%
10-year avg
44.53%
KemPharm, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KemPharm, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like KemPharm, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is KemPharm, Inc.'s ROE?
How is the ROE calculated for KemPharm, Inc. (KMPH)?
What is the highest ROE for KemPharm, Inc. (KMPH)?
What is the 3-year average ROE for KemPharm, Inc. (KMPH)?
What is the 5-year average ROE for KemPharm, Inc. (KMPH)?
How does the current ROE for KemPharm, Inc. (KMPH) compare to its historical average?